Resul Karakuş

Resul Karakuş

Auto-generated profile, based on publicly available information

Resul Karakuş

Department of Obstetrics and Gynecology Zeynep Kamil Women and Children Diseases Training and Research Hospital Istanbul Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Archives of Medical Science
Verified
Journal Article
Open access
ATAhter Tanay Tayyar
Ahter Tanay Tayyar
ATAhmet Tayyar
Ahmet Tayyar
TATolga Atakul
Tolga Atakul
CYCigdem Abide Yayla
Cigdem Abide Yayla
CKCetin Kilicci
Cetin Kilicci
MTMehmet Tayyar
Mehmet Tayyar
The aim of this study is to compare first- and second-trimester Down syndrome biochemical screening markers in intrahepatic cholestasis of pregnancy (ICP) and normal pregnancies. This observational case-control study was conducted at Health Sciences University Zeynep Kamil Maternity and Children's Health Training and Research Hospital and the Department of Obstetrics and Gynecology at Erciyes University Medical Faculty during 2016-2017. The study included 165 patients, and consisted of 62 women who had been diagnosed with ICP (the ICP-diagnosed group) and 103 healthy pregnant women (the control group). First-trimester free β-human chorionic gonadotropin (β-hCG), pregnancy-associated plasma protein-A (PAPP-A) and second-trimester total β-hCG, estriol (E3), α-fetoprotein (AFP), and inhibin A levels were compared between the two groups. The mean patient age was 28.67 ±5.96 years, with no significant difference between the groups (p > 0.05). Average PAPP-A levels were significantly lower in the ICP-diagnosed group (p < 0.001). When the cut-off value for PAPP-A was taken as ≤ 0.93 multiple of median (MoM), the sensitivity and specificity values for ICP were 73.8% and 56.3%, respectively (95% CI, AUC ± SE: 0.663 ±0.042). The decrease in PAPP-A MoM value indicates an increase in the risk of developing ICP, while changes in other markers were not sufficient to predict ICP.

13 September 2021 in Gynecology Obstetrics & Reproductive Medicine
Verified
Journal Article
Open access
PDF file
RKResul Karakus
Resul Karakus
CKCetin Kilicci
Cetin Kilicci
EOEnis Ozkaya
Enis Ozkaya
EDEzgi Darici
Ezgi Darici
OTOnder Tosun
Onder Tosun
AAAli Aras
Ali Aras
OBJECTIVE: We explored the association between hypertension (>140/90) at the latent phase of labor (resistant hypertension) and the subsequent development of major maternal complications or adverse infant outcomes in women with preeclampsia under medical care. STUDY DESIGN: We drew data from 824 women who were under follow-up at the Department of Perinatology of Health Sciences University Zeynep Kamil Women and Children’s Health Training and Research Hospital with a diagnosis of preeclampsia. Women with and without resistant hypertension were compared in terms of major maternal complications and adverse infant outcomes. RESULTS: Mean age and body mass index were similar between the two groups (p>0.05). The rate of preeclamptic complaints was significantly higher in groups with resistant hypertension (90.1% vs. 67.2%, p<0.05). Proteinuria was more frequent in the resistant hypertension group (78.7% vs. 66.8%, p<0.001). The newborn intensive care unit admission rate was significantly higher in the group with resistant hypertension (65.6% vs. 45.9%, p<0.001). Gestational age at delivery was significantly lower in the group with resistant hypertension compared to the normotensive group (34.6 vs. 32.9 weeks, p<0.001). There was a significant difference between the two groups in terms of the rate of preterm delivery (78.5% vs. 66.7%, p=0.04). CONCLUSION: Resistant hypertension is associated with a higher rate of preeclamptic symptoms during labor and newborn intensive care unit admission.

24 March 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
GIGizem boz izceyhan
Gizem boz izceyhan
RKResul Karakuş
Resul Karakuş
MEMina Erbıyık
Mina Erbıyık
Introduction: Interpregnancy interval (IPI) plays a critical role in neonatal health, yet optimal spacing remains controversial. This study assessed neonatal outcomes across short and long IPI using three complementary classification approaches to identify consistent patterns of risk. Materials and Methods: In this retrospective cohort study, medical records of 1194 women with a prior live birth who delivered singleton pregnancies in 2024 at a tertiary referral center were analyzed. IPI was calculated as the delivery-to-conception interval (LMP + 14 days). Three IPI classification systems were applied: (1) classical cut-offs (<6, 6–11, 12–23, 24–59, and ≥60 months), (2) quartiles, and (3) tertiles. Primary outcomes included preterm birth, low birth weight (LBW), and NICU admission. Multivariable logistic regression models adjusted for maternal age, gravidity, and previous cesarean delivery. Results: Short IPI (6–11 months) demonstrated the highest NICU admission rates (29.4%). Very long IPI (≥60 months) showed the highest prevalence of LBW (16.6%). Multivariable regression analysis revealed that intervals ≥ 24 months were independently protective against preterm birth (24–59 months: aOR 0.48, p = 0.002; ≥60 months: aOR 0.58, p = 0.042), while maternal age increased preterm birth risk by 7% per year. Short IPI (6–11 months) and very long IPI (≥60 months) independently increased NICU admission risk (aOR 2.29, p = 0.002 and aOR 1.61, p = 0.036, respectively). Previous cesarean delivery was an independent predictor of NICU admission (aOR 1.35; p = 0.048). Conclusions: Short and very long IPIs are associated with increased neonatal morbidity, particularly NICU admission, while the apparent preterm risk in long intervals is largely mediated by maternal age. Once adjusted, IPIs exceeding 24 months demonstrate protective effects against preterm birth. However, the rising trend toward LBW and NICU admission in intervals beyond 5 years suggests that birth-spacing counseling targeting an optimal window of 18–24 months provides the best balance in minimizing competing neonatal risks.

21 August 2026 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
LULütfiye Uygur
Lütfiye Uygur
ATAbdullah Tabakçı
Abdullah Tabakçı
IAIşıl Ayhan
Işıl Ayhan
HSHazal Sağkol
Hazal Sağkol
CUCeren Unal
Ceren Unal
MÖMucize Eriç Özdemir
Mucize Eriç Özdemir

7 October 2025 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
CKCetin Kilicci
Cetin Kilicci
RKResul Karakus
Resul Karakus
RİReyyan Gökçen İşcan
Reyyan Gökçen İşcan
SKSultan Seren Karakuş
Sultan Seren Karakuş
OTOnder Tosun
Onder Tosun
TATurhan Aran
Turhan Aran

18 February 2026 in Sexuality and Disability
Verified
Journal Article
Closed access
PDF file
HTHamide Arslan Tarus
Hamide Arslan Tarus
NDNurdan Demirci
Nurdan Demirci
SKSultan Seren Karakuş
Sultan Seren Karakuş
RKResul Karakuş
Resul Karakuş